LP19960-1
Cefdinir
Active
Description
Cefdinir (marketed by Abbott Laboratories under the brand name Omnicef) is a semi-synthetic, broad-spectrum antibiotic in the third generation of the cephalosporin class, proven effective for common bacterial infections of the ear, sinus, throat, and skin. It was approved by the U.S. Food and Drug Administration (FDA) in December 1997. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Cefdinir
Basic Part Properties
- Part Display Name
- Cefdinir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Cefdinir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP19960-1 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP19960-1
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 头孢地尼 |
fr-CA | French (Canada) | Cefdinir |
et-EE | Estonian (Estonia) | Tsefdiniir |
es-ES | Spanish (Spain) | Cefdinir |
it-IT | Italian (Italy) | Cefdinir |
tr-TR | Turkish (Turkey) | Sefdinir |
ru-RU | Russian (Russian Federation) | Цефдинир |
nl-NL | Dutch (Netherlands) | cefdinir |
fr-BE | French (Belgium) | Cefdinir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright